« Unlocking the Hidden Capacity of Process Plants | Main | Rosemount Analytical Inc. Oxymitter (OXT) 5000 Rev 4 Fieldbus Device Files »
June 5, 2008
Emerson Solutions presented at 3rd Annual MES Conference
Mark your calendar for the 3rd Annual MES Conference, which convenes manufacturing decision-makers from the pharmaceutical, biotech and medical device communities. This meeting is a superb opportunity to exchange ideas and solutions for next-generation manufacturing IT infrastructures. Discuss current plant-level IT needs and discover the latest and best ways to implement a MES system for future success.
August 5-6, 2008 – MES in the Life Science Industry in Philadelphia, PA
Three speakers are presenting about Emerson solutions:
Laying the MES Groundwork through ISA 88 Process Mapping and Batch Record Standardization — Shire's Story by Samantha Krebs, Senior Process Improvement Technical Writer, Shire Pharmaceuticals, Inc.
Prior to putting the first foot in the “MES waters”, it is critical that life science organizations plan and execute the necessary pre-MES groundwork. Ultimate MES success and measurable results depend upon the early establishment of a strong MES foundation. This session discusses the steps taken at Shire to establish a good foundation for an MES project, scheduled to kick-off in mid-2008. Learn how Shire walked through the planning, process mapping and standardization necessary for MES success.
- ISA 88 Mapping — How ISA 88 mapping probed through four levels
- Leveraging ISA 88 process mapping to generalize maps configurable for any future products
- Batch Record Standardization — How batch records were first standardized on paper before going electronic
Case Study Update — Implementing a Highly Integrated MES and the Results to Date at BMS’ Devens Biopharmaceutical Manufacturing Facility by Tony Fenn, Senior Principal Engineer, Bristol-Myers Squibb
Bristol-Myers Squibb is investing $750 million in the construction of a Large-Scale Cell Culture (LSCC) manufacturing facility in Devens , MA , for the commercial production of biopharmaceuticals. The BMS vision is to implement a fully automated, paperless solution that supports release by exception utilizing S95/S88 integrated recipes. This is to be executed using an MES to orchestrate plant floor automation, lab activity and materials management. This case study provides an update on the project thus far and shares key results and lessons learned to date.
- Recap on the architecture and design of BMS' Manufacturing Operational Philosophy, with an emphasis on the MES
- Interface Design — The what and how of working with SAP, LIMS and Maximo
- Recipe Design, equipment versus process functions and “reusable recipe patterns”
- Project Methodology — Proof through use, rapid programming approach, preliminary build versus final build, teams and skill sets
Industry Directions for MES Adoption, Integration and Standards
This panel discussion convenes industry MES leaders and trailblazers to discuss the state of MES adoption, challenges in achieving integration and the future of standards adoption.
- Views on the level of MES sophistication to date
- New enhancements and advancements in systems and processes
- Most problematic challenges in achieving MES interoperability and enterprise-wide integration
- Outlook for standards adoption and the need for further standardization
Moderator: Tony Fenn, Principal Engineer, Bristol-Myers Squibb
Panelists:
Paul Brandenburg, Team Lead, Site Execution Systems, Eli Lilly & Co
Michael Asher, Control Engineer, GlaxoSmithKline
Keith T. Evans, Biotech OpU MES Focal Point, TO&PS BSP, Wyeth Pharmaceuticals
Cathal Strain, Senior Director and Team Leader, API Automation, Pfizer Inc
Posted by Emerson's EasyDeltaV.com on June 5, 2008 | TrackBack (0)
TrackBacks
TrackBack URL for this entry:
http://news.easydeltav.com/mt/mt-tb.cgi/747
Listed below are links to weblogs that reference Emerson Solutions presented at 3rd Annual MES Conference: